相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P. Fendler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Combination of [68Ga]Ga-PSMA PET/CT and [18F]FDG PET/CT in demonstrating dedifferentiation in castration-resistant prostate cancer
F. Kepenek et al.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE (2023)
The Prognostic Value of Posttreatment 68Ga-PSMA-11 PET/ CT and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)
Sarennya Pathmanandavel et al.
JOURNAL OF NUCLEAR MEDICINE (2023)
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Clemens Kratochwil et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Patients With Gray Zone PSA Levels: Application of Prostate MRI and MRS in the Diagnosis of Prostate Cancer
Xue Li et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature
Judith Stangl-Kremser et al.
PROSTATE (2023)
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy
Raphael Metz et al.
CANCERS (2023)
Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography
André N. Vis et al.
European Urology Oncology (2023)
161Tb-PSMA Unleashed: a Promising New Player in the Theranostics of Prostate Cancer
Akram Al-Ibraheem et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
Ruohua Chen et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
Christiane Schuchardt et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
212Pb: Production Approaches and Targeted Therapy Applications
Konstantin V. Kokov et al.
PHARMACEUTICS (2022)
Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma
Joshua Gu et al.
CLINICAL NUCLEAR MEDICINE (2022)
The added value of PSMA PET/MR radiomics for prostate cancer staging
Esteban Lucas Solari et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C. Mease et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
James A. Eastham et al.
JOURNAL OF UROLOGY (2022)
Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONECIRCLED LATIN CAPITAL LETTER R Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy
Shigeaki Higashiyama et al.
UROLOGIA INTERNATIONALIS (2022)
Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review
Jamie Michael et al.
CANCER MANAGEMENT AND RESEARCH (2022)
Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
Manuela A. Hoffmann et al.
CANCERS (2022)
[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
Anna Giulia Nappi et al.
CANCERS (2022)
Exploring wait time variations in a prostate cancer patient pathway-A qualitative study
Anne Grete Valbekmo et al.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2022)
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
Knut Liepe et al.
WORLD JOURNAL OF NUCLEAR MEDICINE (2022)
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
Kevin H. Leung et al.
EJNMMI RESEARCH (2022)
Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7
Ebrahim Tasmeera et al.
MEDICINE (2022)
Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
Zhuonan Wang et al.
FRONTIERS IN ONCOLOGY (2022)
Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging
Audrey Asuncion et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2022)
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)
Louise Kostos et al.
FRONTIERS IN MEDICINE (2022)
Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions
Michela Gravina et al.
DIAGNOSTICS (2022)
Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
Sui Wai Ling et al.
PHARMACEUTICS (2022)
Role of MRI, Ultrasound, and Computed Tomography in the Management of Prostate Cancer
Nancy Mohsen
PET CLINICS (2022)
Neoadjuvant 177Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial
Shay Golan et al.
European Urology Oncology (2022)
[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature
Laura Evangelista et al.
EUROPEAN UROLOGY ONCOLOGY (2022)
[18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
Cristina Ferrari et al.
TOMOGRAPHY (2022)
Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review
Elizabeth E. Ellis et al.
THERAPEUTIC ADVANCES IN UROLOGY (2022)
Ultra-high-field MR in Prostate cancer: Feasibility and Potential
Carlijn J. A. Tenbergen et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2022)
High resolution magic angle spinning MRS in prostate cancer
Matteo Sanchez-Dahl Gonzalez et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2022)
The role of MRI in prostate cancer: current and future directions
Maria Clara Fernandes et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2022)
Radium-223 in mCPRC patients: a large real-life Italian multicenter study
Viviana Frantellizzi et al.
MINERVA UROLOGY AND NEPHROLOGY (2022)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2021)
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
Michele Klain et al.
FUTURE SCIENCE OA (2021)
Radium-223 therapy for metastatic castration-resistant prostate cancer: survival benefit when used earlier in the treatment pathway
Peter Jarvis et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
The Role of Theranostics in Prostate Cancer
Elisabeth O'Dwyer et al.
SEMINARS IN RADIATION ONCOLOGY (2021)
Clinically Significant Prostate Cancer Detection With Biparametric MRI: A Systematic Review and Meta-Analysis
Renato Cuocolo et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Michael J. Morris et al.
CLINICAL CANCER RESEARCH (2021)
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
Daniela A. Ferraro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J. Pienta et al.
JOURNAL OF UROLOGY (2021)
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
Matteo Bauckneht et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2021)
Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
Florian Rosar et al.
PHARMACEUTICS (2021)
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks
E. M. Abbott et al.
CLINICAL ONCOLOGY (2021)
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
Lucia Zanoni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Combined 177Lu-PSMA-617 PRLT and abiraterone acetate versus 177Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability
Sonam Suman et al.
PROSTATE (2021)
Detection of Clinically Significant Prostate Cancer by Systematic TRUS-Biopsies in a Population-Based Setting Over a 20 Year Period
Sandra Miriam Kawa et al.
UROLOGY (2021)
MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
Dong He et al.
CANCER IMAGING (2021)
Competitive blocking of salivary gland [18F]DCFPyL uptake via localized, retrograde ductal injection of non-radioactive DCFPyL: a preclinical study
Jyoti Roy et al.
EJNMMI RESEARCH (2021)
Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?
William John Yaxley et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2021)
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake
Karine Sahakyan et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Matched-Pair Comparison of Ga-68-PSMA-11 PET/CT and F-18-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
Isabel Rauscher et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
PSMA-Based Theranostics: A Step-by-Step Practical Approach to Diagnosis and Therapy for mCRPC Patients
Hojjat Ahmadzadehfar et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
Fadi Khreish et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
[F-18]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0
Cristina Nanni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
Andrew F. Scarsbrook et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Edouard J. Trabulsi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Introduction to Radiomics
Marius E. Mayerhoefer et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Radiation Dosimetry in Lu-177-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H. E. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Prostate MRI radiomics: A systematic review and radiomic quality score assessment
Arnaldo Stanzione et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
Felipe de Galiza Barbosa et al.
CANCER IMAGING (2020)
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
Nicola Fossati et al.
JOURNAL OF UROLOGY (2020)
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips et al.
JAMA ONCOLOGY (2020)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Parker et al.
ANNALS OF ONCOLOGY (2020)
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
Gerald L. Andriole et al.
JOURNAL OF UROLOGY (2019)
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
Baris Turkbey et al.
EUROPEAN UROLOGY (2019)
The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer
Henk van der Poel et al.
WORLD JOURNAL OF UROLOGY (2019)
Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team
Declan G. Murphy et al.
BJU INTERNATIONAL (2019)
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Cristina Muller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
Jose Mauricio Mota et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT
Birgit Pernthaler et al.
CLINICAL NUCLEAR MEDICINE (2019)
TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)
Michael S. Hofman et al.
BJU INTERNATIONAL (2019)
Prostate MRI technical parameters standardization: A systematic review on adherence to PI-RADSv2 acquisition protocol
Renato Cuocolo et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
John Violet et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
Olivier Rouviere et al.
LANCET ONCOLOGY (2019)
A review of optimal prostate biopsy: indications and techniques
Justin Streicher et al.
THERAPEUTIC ADVANCES IN UROLOGY (2019)
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy
Sue Ping Thang et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Prospective evaluation of F-18-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
Ivan Jambor et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
64CuCl2 PET/CT in Prostate Cancer Relapse
Arnoldo Piccardo et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies
Steven P. Rowe et al.
EUROPEAN UROLOGY (2018)
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
Thomas Lindner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617:Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate
Ming Zhou
MODERN PATHOLOGY (2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Imaging of Prostate Cancer Using C-11-Choline PET/Computed Tomography
Paolo Castellucci et al.
UROLOGIC CLINICS OF NORTH AMERICA (2018)
Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT
Thomas J. W. Klein Nulent et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2018)
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2018)
Pitfalls in Gallium-68 PSMA PET/CT Interpretation-A Pictorial Review
Deepa Shetty et al.
TOMOGRAPHY (2018)
Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake
Xin Li et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Complications After Systematic, Random, and Image-guided Prostate Biopsy
Marco Borghesi et al.
EUROPEAN UROLOGY (2017)
Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer
Kenichi Nakajima et al.
INTERNATIONAL JOURNAL OF UROLOGY (2017)
177Lu-PSMA Radioligand Therapy for Prostate Cancer
Wolfgang P. Fendler et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification
Bimal Bhindi et al.
JOURNAL OF UROLOGY (2017)
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer
Tore Bach-Gansmo et al.
JOURNAL OF UROLOGY (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy
Wen-jun Xiao et al.
PLOS ONE (2017)
Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models
Tsutomu Tamada et al.
RADIOLOGY (2017)
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intent
Simon Gauvin et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
Ryogo Minamimoto et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
The EANM practice guidelines for bone scintigraphy
T. Van den Wyngaert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2016)
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
Richard P. Baum et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Gastrin-Releasing Peptide Receptor (GRPr) Promotes EMT, Growth, and Invasion in Canine Prostate Cancer
Said M. Elshafae et al.
PROSTATE (2016)
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Maurizio Conti et al.
EJNMMI PHYSICS (2016)
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology
Gary J. R. Cook et al.
CLINICAL AND TRANSLATIONAL IMAGING (2016)
Role of 64CuCl2 PET/CT in staging of prostate cancer
Enza Capasso et al.
ANNALS OF NUCLEAR MEDICINE (2015)
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
Amanda Nicholson et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease
Che-kai Tsao et al.
JOURNAL OF UROLOGY (2015)
Initial Evaluation of [F-18]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Zsolt Szabo et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Imaging and evaluation of patients with high-risk prostate cancer
Marc A. Bjurlin et al.
NATURE REVIEWS UROLOGY (2015)
Test-Retest Reproducibility Analysis of Lung CT Image Features
Yoganand Balagurunathan et al.
JOURNAL OF DIGITAL IMAGING (2014)
Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil
Kazuhiro Kitajima et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system
Phillip M. Pierorazio et al.
BJU INTERNATIONAL (2013)
Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment
Beatrice Detti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Radiolabeled Amino Acids for Oncologic Imaging
Chaofeng Huang et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Liver SULmean at FDG PET/CT: Interreader Agreement and Impact of Placement of Volume of Interest
Maya Viner et al.
RADIOLOGY (2013)
ESUR prostate MR guidelines 2012
Jelle O. Barentsz et al.
EUROPEAN RADIOLOGY (2012)
Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates
Marc Beer et al.
PROSTATE (2012)
A Clinically Relevant Approach to Imaging Prostate Cancer: Review
Sadhna Verma et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
Marco Auprich et al.
EUROPEAN UROLOGY (2011)
Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature
Mary K. Samplaski et al.
MODERN PATHOLOGY (2011)
Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions
David Bonekamp et al.
RADIOGRAPHICS (2011)
Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In-Capromab Pendetide SPECT/CT
David M. Schuster et al.
RADIOLOGY (2011)
Astatine-211: Production and Availability
Michael R. Zalutsky et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy
Chiara Fuccio et al.
ANNALS OF NUCLEAR MEDICINE (2010)
DETECTION OF LOCAL, REGIONAL, AND DISTANT RECURRENCE IN PATIENTS WITH PSA RELAPSE AFTER EXTERNAL-BEAM RADIOTHERAPY USING 11C-CHOLINE POSITRON EMISSION TOMOGRAPHY
Anthonius J. Breeuwsma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
18F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients
Mohsen Beheshti et al.
RADIOLOGY (2010)
Predictive Value of PCA3 in Urinary Sediments in Determining Clinico-Pathological Characteristics of Prostate Cancer
Daphne Hessels et al.
PROSTATE (2010)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer
Hildo J. K. Ananias et al.
PROSTATE (2009)
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer
David Schilling et al.
BJU INTERNATIONAL (2008)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
PCA3 molecular urine assay correlates with prostate cancer tumor volume: Implication in selecting candidates for active surveillance
Hiroyuki Nakanishi et al.
JOURNAL OF UROLOGY (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability
Sigrid A. Rajasekaran et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer
E. Pelosi et al.
RADIOLOGIA MEDICA (2008)
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer
Ludwig Rinnab et al.
BJU INTERNATIONAL (2007)
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: A study of pharmacokinetic parameters
Iclal Ocak et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Dynamic contrast enhanced MRI in prostate cancer
Roberto Alonzi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy:: Results confirmed by open pelvic-retroperitoneal lymphadenectomy
Vincenzo Scattoni et al.
EUROPEAN UROLOGY (2007)
Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer
Masoom A. Haider et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Imaging prostate cancer: A multidisciplinary perspective
Hedvig Hricak et al.
RADIOLOGY (2007)
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
Andrew J. Stephenson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone
H Li et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Endorectal MR imaging before salvage prostatectomy: Tumor localization and staging
E Sala et al.
RADIOLOGY (2006)
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury
DJ Bacich et al.
JOURNAL OF NEUROCHEMISTRY (2005)
The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
MR Cooperberg et al.
JOURNAL OF UROLOGY (2005)
Early prostate cancer: Prevention, treatment modalities, and quality of life issues
JW Moul et al.
EUROPEAN UROLOGY (2003)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)